FDA Inspection
ACTA Laboratories, Inc.ACTA Laboratories, Inc. – FDA Inspection, Jan 19, 2018
Record Details
This FDA Inspection record concerns ACTA Laboratories, Inc., with an inspection on January 19, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 9a360f63-297b-425c-827b-c3ff338b639a
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1038484
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
3- 21 CFR 211.192No written record of investigation
- 21 CFR 211.194(a)(2)Suitability of testing methods verified
- 21 CFR 211.68(b)Computer control of master formula records
Full citation text and observation details available on the Dashboard.
Other FDA inspections of ACTA Laboratories, Inc.
6| Date | Classification | Office | Project area |
|---|---|---|---|
| September 4, 2026 | VAI | Los Angeles District Office | Drug Quality Assurance |
| February 13, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 11, 2014 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 14, 2011 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 30, 2010 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for ACTA Laboratories, Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.